About

Freenome is dedicated to advancing cancer detection through its multiomics platform, which integrates advanced machine learning techniques to analyze patterns in circulating biomarkers. This company is notable for its emphasis on early-stage colorectal cancer and advanced adenomas detection, positioning itself at the forefront of medical innovation in oncology. The collaborative and forward-thinking work environment, coupled with a mission-driven approach, makes it an appealing place for professionals looking to impact public health significantly.